Wang et al. observed that cotreatment with metformin and sitagliptin attenuated the apoptosis in PCOS model cells by inducing lncRNA H19 expression and proposed the three-combined strategy (metformin-sitagliptin-H19-expressing lentiviruses) for the treatment of PCOS [14]. The gene discussed is H19; the disease is polycystic ovary syndrome.